Seelos Therapeutics, Inc. Financial Flexibility Index
Seelos Therapeutics, Inc. financial flexibility index. Seelos Therapeutics, Inc. (SEELQ) has a Financial Flexibility Index of -0.03x as of June 2024. Free cash flow of $-972.00K (operating CF $-972.00K minus capex $0.00) represents 0% of total liabilities ($30.51 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Seelos Therapeutics, Inc. (2020–2023)
Financial flexibility index of Seelos Therapeutics, Inc. from 2020 to 2023. Historical Financial Flexibility Index trend for Seelos Therapeutics, Inc. across 4 annual periods. Check Seelos Therapeutics, Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Seelos Therapeutics, Inc. Financial Flexibility Index by Year (2020–2023)
Seelos Therapeutics, Inc. financial flexibility index by year from 2020 to 2023. Year-by-year free cash flow to debt coverage for Seelos Therapeutics, Inc.. For the full cash flow conversion analysis, see cash flow conversion of Seelos Therapeutics, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.61x | $-23.91 Million | $-23.91 Million | $38.93 Million | ▲ +66.7% |
| 2022 | -1.85x | $-61.60 Million | $-61.60 Million | $33.36 Million | ▲ +1.3% |
| 2021 | -1.87x | $-48.99 Million | $-48.99 Million | $26.18 Million | ▼ -33.5% |
| 2020 | -1.40x | $-20.91 Million | $-20.91 Million | $14.92 Million | — |